2359 STRATEGIES

Registrant on federal lobbying filings · filed 2025 to 2025

$12,000 Income reported

3 Clients represented

3 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401106114), not by name.

Clients 3

TRAVERE THERAPEUTICS $12,000 1 filing
FEDERAL STREET STRATEGIES LLC $0 1 filing
THE FIBROID FOUNDATION $0 1 filing

Lobbyists named 1

CHARLES DUJON 3 filings · through 2025 Legislative Director, U.S. House of Representatives

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 1 year

2025 $12,000 3 filings

Issues lobbied 11

Health Issues 2
Budget/Appropriations 1
Communications/Broadcasting/Radio/TV 1
Computer Industry 1
Defense 1
Labor Issues/Antitrust/Workplace 1
Medical/Disease Research/Clinical Labs 1
Medicare/Medicaid 1
Pharmacy 1
Taxation/Internal Revenue Code 1
Telecommunications 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 3 total

Q1

THE FIBROID FOUNDATION

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · posted Apr 19, 2025

View → Q1

FEDERAL STREET STRATEGIES LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · posted Apr 19, 2025

View → Q1

TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $12,000 income · posted Apr 19, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.